HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

ATEC

Alphatec Holdings, Inc. (NASDAQ)

Healthcare — Medical Devices

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. The company was founded in 1990 and is headquartered in Carlsbad, California.

None 11 analysts
$8.06
$-0.24 (-2.89%)
Target: $16.73 (107.5%)
Sign in to add ATEC to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$1.33B
P/E Ratio (TTM)-
Forward P/E14.97
EPS (TTM)$-0.83
Dividend Yield-
Profit Margin-15.93%
Revenue Growth13.60%
ROE-
Debt/Equity3303.35
Recommendation None
Analyst Target$16.73
Analysts11
Indexes NASDAQ

Technical Indicators

RSI (14)55.8
Beta0.87
SMA 20-
SMA 40-
52-Week High$23.29
52-Week Low$6.82
50-Day Avg$8.67
200-Day Avg$14.21
Avg Volume$3.57M
Volume$2.04M

Performance Analysis

NEUTRAL

ATEC presents a mixed picture with both positive and negative indicators.

+ Trading near its 52-week low ($6.82), which could present a value opportunity.
+ RSI at 55.8 shows positive momentum.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
~ Modest revenue growth of 13.6% year-over-year.
- Operating at a loss with -15.9% margin.
~ Wall Street consensus is "none" from 11 analysts.
+ Average analyst target of $16.73 implies 107.5% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jun 30, 2026 21:07 UTC

Back to Screener Export Report